sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology
The Vanguard Group, Inc. has submitted a Form 8.3 to the Irish Takeover Panel. This document pertains to Mural Oncology plc, revealing Vanguard's position regarding the company's securities. As of June 27, 2025, Vanguard holds 772,851 ordinary shares, accounting for 4.48% of Mural Oncology's shares.
The disclosure includes a sale of 64 shares at a price of 2.48 USD each. No cash-settled or stock-settled derivative transactions have been reported. Additionally, there are no indemnities, agreements, or understandings influencing securities dealing or voting rights. Vanguard confirmed no supplemental Form 8 was necessary.
This form ensures compliance with Rule 8.3 of the Irish Takeover Panel Act, 1997, concerning stakeholders with significant interest or positions in relevant securities.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.